320 related articles for article (PubMed ID: 29746314)
1. Impact of Anticoagulation and Circuit Technology on Complications During Extracorporeal Membrane Oxygenation.
Niebler RA; Parker H; Hoffman GM
ASAIO J; 2019; 65(3):270-276. PubMed ID: 29746314
[TBL] [Abstract][Full Text] [Related]
2. Venovenous Extracorporeal Membrane Oxygenation With Prophylactic Subcutaneous Anticoagulation Only: An Observational Study in More Than 60 Patients.
Krueger K; Schmutz A; Zieger B; Kalbhenn J
Artif Organs; 2017 Feb; 41(2):186-192. PubMed ID: 27256966
[TBL] [Abstract][Full Text] [Related]
3. Outcomes following routine antithrombin III replacement during neonatal extracorporeal membrane oxygenation.
Stansfield BK; Wise L; Ham PB; Patel P; Parman M; Jin C; Mathur S; Harshfield G; Bhatia J
J Pediatr Surg; 2017 Apr; 52(4):609-613. PubMed ID: 27847121
[TBL] [Abstract][Full Text] [Related]
4. The Impact and Statistical Analysis of a Multifaceted Anticoagulation Strategy in Children Supported on ECMO: Performance and Pitfalls.
Kessel AD; Kline M; Zinger M; McLaughlin D; Silver P; Sweberg TM
J Intensive Care Med; 2017 Jan; 32(1):59-67. PubMed ID: 26319579
[TBL] [Abstract][Full Text] [Related]
5. The use of an extracorporeal membrane oxygenation anticoagulation laboratory protocol is associated with decreased blood product use, decreased hemorrhagic complications, and increased circuit life.
Northrop MS; Sidonio RF; Phillips SE; Smith AH; Daphne HC; Pietsch JB; Bridges BC
Pediatr Crit Care Med; 2015 Jan; 16(1):66-74. PubMed ID: 25319630
[TBL] [Abstract][Full Text] [Related]
6. Conversion From Activated Clotting Time to Anti-Xa Heparin Activity Assay for Heparin Monitoring During Extracorporeal Membrane Oxygenation.
Figueroa Villalba CA; Brogan TV; McMullan DM; Yalon L; Jordan DI; Chandler WL
Crit Care Med; 2020 Dec; 48(12):e1179-e1184. PubMed ID: 33009103
[TBL] [Abstract][Full Text] [Related]
7. Antifactor Xa Monitoring and Hematologic Complications of Pediatric Extracorporeal Membrane Oxygenation.
Rama G; Middlesworth W; Neunert C; Streltsova S; Cheung EW
ASAIO J; 2021 Jan; 67(1):91-95. PubMed ID: 33346994
[TBL] [Abstract][Full Text] [Related]
8. Anti-xa directed protocol for anticoagulation management in children supported with extracorporeal membrane oxygenation.
O'Meara LC; Alten JA; Goldberg KG; Timpa JG; Phillips J; Laney D; Borasino S
ASAIO J; 2015; 61(3):339-44. PubMed ID: 25710768
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a pharmacy managed heparin protocol for extracorporeal membrane oxygenation patients.
Fitousis K; Klasek R; Mason PE; Masud F
Perfusion; 2017 Apr; 32(3):238-244. PubMed ID: 27837164
[TBL] [Abstract][Full Text] [Related]
10. Conventional versus restricted anti-Xa-guided heparin protocol in adult patients undergoing extracorporeal membrane oxygenation.
Alkazemi A; Eche IM; Adra M; Cabezas F; Patel P; Rick K; Grandin EW
Artif Organs; 2022 Jan; 46(1):128-137. PubMed ID: 34725832
[TBL] [Abstract][Full Text] [Related]
11. Comparison of routine laboratory measures of heparin anticoagulation for neonates on extracorporeal membrane oxygenation.
Sulkowski JP; Preston TJ; Cooper JN; Duffy VL; Deans KJ; Chicoine LG; Minneci PC
J Extra Corpor Technol; 2014 Mar; 46(1):69-76. PubMed ID: 24779122
[TBL] [Abstract][Full Text] [Related]
12. Performance Assessment of a Multifaceted Unfractionated Heparin Dosing Protocol in Adult Patients on Extracorporeal Membrane Oxygenator.
Al-Jazairi A; Raslan S; Al-Mehizia R; Dalaty HA; De Vol EB; Saad E; Alanazi M; Owaidah T
Ann Pharmacother; 2021 May; 55(5):592-604. PubMed ID: 32959678
[TBL] [Abstract][Full Text] [Related]
13. Prospective Side by Side Comparison of Outcomes and Complications With a Simple Versus Intensive Anticoagulation Monitoring Strategy in Pediatric Extracorporeal Life Support Patients.
Yu JS; Barbaro RP; Granoski DA; Bauman ME; Massicotte MP; Lequier LL; Annich GM; Ryerson LM
Pediatr Crit Care Med; 2017 Nov; 18(11):1055-1062. PubMed ID: 28922263
[TBL] [Abstract][Full Text] [Related]
14. Coagulation and anticoagulation in extracorporeal membrane oxygenation.
Muntean W
Artif Organs; 1999 Nov; 23(11):979-83. PubMed ID: 10564301
[TBL] [Abstract][Full Text] [Related]
15. Bleeding, Thrombosis, and Transfusion With Two Heparin Anticoagulation Protocols in Venoarterial ECMO Patients.
Mazzeffi MA; Tanaka K; Roberts A; Rector R; Menaker J; Kon Z; Deatrick KB; Kaczorowski D; Griffith B; Herr D
J Cardiothorac Vasc Anesth; 2019 May; 33(5):1216-1220. PubMed ID: 30181084
[TBL] [Abstract][Full Text] [Related]
16. Unfractionated heparin activity measured by anti-factor Xa levels is associated with the need for extracorporeal membrane oxygenation circuit/membrane oxygenator change: a retrospective pediatric study.
Irby K; Swearingen C; Byrnes J; Bryant J; Prodhan P; Fiser R
Pediatr Crit Care Med; 2014 May; 15(4):e175-82. PubMed ID: 24622165
[TBL] [Abstract][Full Text] [Related]
17. Anticoagulation monitoring during pediatric extracorporeal membrane oxygenation.
Bembea MM; Schwartz JM; Shah N; Colantuoni E; Lehmann CU; Kickler T; Pronovost P; Strouse JJ
ASAIO J; 2013; 59(1):63-8. PubMed ID: 23263338
[TBL] [Abstract][Full Text] [Related]
18. Pilot study evaluating a non-titrating, weight-based anticoagulation scheme for patients on veno-venous extracorporeal membrane oxygenation.
Deatrick KB; Galvagno SM; Mazzeffi MA; Kaczoroswki DJ; Herr DL; Rector R; Hochberg E; Rabinowitz RP; Scalea TM; Menaker J
Perfusion; 2020 Jan; 35(1):13-18. PubMed ID: 31122144
[TBL] [Abstract][Full Text] [Related]
19. Performance Assessment of Anti-Xa Assay-Based Heparin Dosing Protocol in Pediatric Patients on Extracorporeal Membrane Oxygenation.
Al-Jazairi AS; Shorog EM; Owaidah TM; Al Dalaty H; Alheriash YA; Almehizia RA; Alahmadi MD
World J Pediatr Congenit Heart Surg; 2023 Nov; 14(6):723-728. PubMed ID: 37654250
[TBL] [Abstract][Full Text] [Related]
20. Anticoagulation Monitoring Under ECMO Support: A Comparative Study Between the Activated Coagulation Time and the Anti-Xa Activity Assay.
Delmas C; Jacquemin A; Vardon-Bounes F; Georges B; Guerrero F; Hernandez N; Marcheix B; Seguin T; Minville V; Conil JM; Silva S
J Intensive Care Med; 2020 Jul; 35(7):679-686. PubMed ID: 29768983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
